Gunveen Kaur1, Xiao-Fei Guo, Andrew J Sinclair. 1. aCentre for Physical Activity and Nutrition Research (CPAN), School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia bDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China cSchool of Medicine, Deakin University, Geelong dDepartment of Nutrition and Dietetics, Monash University, Melbourne, Australia eDepartment of Food Science and Nutrition, Zhejiang University, Hangzhou, China.
Abstract
PURPOSE OF REVIEW: Docosapentaenoic acid (DPA) is a long-chain n-3 polyunsaturated fatty acid that is intermediary between eicosapentaenoic acid and docosahexaenoic acid in the n-3 synthesis pathway. DPA is part of our normal diet through fish and lean red meat. In recent years, DPA has received increasing attention as an important bioactive fatty acid in light of its potential beneficial health effects, which include anti-inflammatory actions, antiplatelet aggregation, and improved plasma lipid prolife. This review provides a short summary of the most recent research on DPA. RECENT FINDINGS: In this review, we report on the latest association data as well as data generated from in-vitro and in-vivo studies on DPA and cardiovascular health, mental health, inflammation, and cancer. We also report on the newly identified DPA metabolites and their effects on exacerbation of inflammation in animal models. SUMMARY: Although there is a growing body of evidence supporting DPA's role as an important bioactive fatty acid, there is a need for more 'cause and effect studies', clinical trials and studies which can reveal whether DPA plays separate roles to those identified for eicosapentaenoic acid and docosahexaenoic acid.
PURPOSE OF REVIEW: Docosapentaenoic acid (DPA) is a long-chain n-3 polyunsaturated fatty acid that is intermediary between eicosapentaenoic acid and docosahexaenoic acid in the n-3 synthesis pathway. DPA is part of our normal diet through fish and lean red meat. In recent years, DPA has received increasing attention as an important bioactive fatty acid in light of its potential beneficial health effects, which include anti-inflammatory actions, antiplatelet aggregation, and improved plasma lipid prolife. This review provides a short summary of the most recent research on DPA. RECENT FINDINGS: In this review, we report on the latest association data as well as data generated from in-vitro and in-vivo studies on DPA and cardiovascular health, mental health, inflammation, and cancer. We also report on the newly identified DPA metabolites and their effects on exacerbation of inflammation in animal models. SUMMARY: Although there is a growing body of evidence supporting DPA's role as an important bioactive fatty acid, there is a need for more 'cause and effect studies', clinical trials and studies which can reveal whether DPA plays separate roles to those identified for eicosapentaenoic acid and docosahexaenoic acid.
Authors: Chesney K Richter; Karl Stessy Bisselou; Tara M Nordgren; Lynette Smith; Adams Kusi Appiah; Nicholas Hein; Ann Anderson-Berry; Penny Kris-Etherton; Corrine Hanson; Ann C Skulas-Ray Journal: Lipids Date: 2019-04 Impact factor: 1.880
Authors: Don V Nguyen; Van H Le; Quang V Nguyen; Bunmi S Malau-Aduli; Peter D Nichols; Aduli E O Malau-Aduli Journal: Nutrients Date: 2017-08-17 Impact factor: 5.717
Authors: Gaetan Drouin; Daniel Catheline; Annaëlle Sinquin; Charlotte Baudry; Pascale Le Ruyet; Vincent Rioux; Philippe Legrand Journal: Front Nutr Date: 2018-05-23
Authors: James R Petrie; Xue-Rong Zhou; Antonio Leonforte; Jason McAllister; Pushkar Shrestha; Yoko Kennedy; Srinivas Belide; Greg Buzza; Nelson Gororo; Wenxiang Gao; Geraldine Lester; Maged P Mansour; Roger J Mulder; Qing Liu; Lijun Tian; Claudio Silva; Noel O I Cogan; Peter D Nichols; Allan G Green; Robert de Feyter; Malcolm D Devine; Surinder P Singh Journal: Front Plant Sci Date: 2020-06-12 Impact factor: 5.753